Quantcast

Latest Medical research Stories

2014-03-03 23:00:07

Georgia State’s new Institute for Biomedical Sciences has opened with a mission of advancing research that improves human health, as well as educating and training future generations of leading biomedical scientists and health professionals. Atlanta, Georgia (PRWEB) March 04, 2014 Georgia State’s new Institute for Biomedical Sciences has opened with a mission of advancing research that improves human health, as well as educating and training future generations of leading biomedical...

2014-03-03 12:26:15

ST. PAUL, Minn., March 3, 2014 /PRNewswire/ -- Data Sciences International (DSI) announced today that Nova Biomedical (Nova) and DSI have signed a supply agreement for the development and manufacture of a fully implanted telemetry device for the continuous measurement of blood glucose in animal research applications. http://photos.prnewswire.com/prnvar/20140107/CG40863LOGO The Centers for Disease Control and Prevention (CDC) estimates that diabetes affects 26 million people in the U.S....

2014-02-27 23:03:20

Resolution Promotes Awareness of Rare Diseases Sacramento, CA (PRWEB) February 27, 2014 Today at the state Capitol, Assemblymember Kevin Mullin (D-South San Francisco), in partnership with the California Healthcare Institute (CHI), presented House Resolution 32 recognizing Feb. 28 as Rare Disease Day in California. CHI is a nonprofit, public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical...

2014-02-27 23:03:10

CareLex, a health sciences BioInformatics company, will continue its focus on open source technologies that accelerate the safe delivery of new therapies to patients under new CEO. Sacramento, California (PRWEB) February 27, 2014 CareLex, an open source health sciences bioinformatics company, announced the appointment of Jennifer Alpert Palchak as CEO. Alpert Palchak has previously served on CareLex’s advisory board and will assume CEO responsibilities immediately. “Clinical...

2014-02-25 23:26:44

Streamlined process will improve efficiency and quality of data collection Reston, Virginia (PRWEB) February 25, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency and productivity of product development, today announced the launch of a new, streamlined process to support endpoint adjudication for drug and medical device companies. Regulatory...

2014-02-18 23:01:28

Experts say the U.S. Supreme Court’s upholding of the individual mandate will benefit biomedical research. Since the Affordable Care Act just went into effect in January 2014, researchers will now see the benefits of the mandate upheld by the U.S. Supreme Court. San Antonio, TX (PRWEB) February 18, 2014 Texas Medical Research Associates, a clinical research facility, say that the Affordable Care Act, in effect as of Jan. 1, 2014, will have a positive impact on biomedical research. The...

2014-02-18 16:26:23

BOULDER, Colo. and SAN FRANCISCO, Feb. 18, 2014 /PRNewswire/ -- With its participation in the 58(th) annual Biophysical Society Meeting from February 15 - 19, along with the 21st International Molecular Medicine Tri-Conference, BiOptix entered a second week highlighting the 404pi SPR platform and new publication data to a global research audience in California. "California continues to be a global center of scientific research," noted Ken Wilczek, Vice President, Sales &...

2014-02-18 12:31:11

CULVER CITY, Calif., Feb. 18, 2014 /PRNewswire-USNewswire/ -- On behalf of the World Molecular Imaging Congress (WMIC) Scientific Program Committee, you are invited to submit an abstract for presentation or publication at the WMIC 2014, September 17 - 20 in Seoul, Korea. "This year's theme, 'Propelling Discoveries with Molecular Imaging', emphasizes the global trend and need to incorporate molecular imaging in research and medicine to discover new targets and agents, visualize and...

2014-02-13 08:30:31

REG2 Extends Regado's Next-Generation Anticoagulation Therapy Franchise as Phase 3 REGULATE-PCI Clinical Trial of REG1 Advances BASKING RIDGE, N.J., Feb. 13, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration (FDA) has accepted the company's...

2014-02-12 08:28:36

New Patent Extends Coverage to Peptide- and Protein-Based Control Agents BASKING RIDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Patent and Trademark Office (USPTO) has issued an important patent that expands protection of Regado's core technology platform...


Latest Medical research Reference Libraries

Bulletin of the World Health Organization
2012-06-04 20:04:03

The Bulletin of the World Health Organization is a public health journal established in 1947 and published monthly by the World Health Organization (WHO). The editor-in-chief is Adetokunbo O. Lucas. The journal aims to offer publish health policy and practice guidance based on the best evidence available, while encouraging closer links between scientific investigation and the art of helping populations to lead healthier lives. Articles are published in English and abstracts are available...

British Journal of Cancer
2012-05-28 10:11:32

The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...

Disease Models & Mechanisms
2012-05-12 21:51:28

Disease Models & Mechanisms (DMM) is a peer-reviewed open-access biomedical journal published by The Company of Biologists, a UK non-profit publisher of international biological journals, such as Journal of Cell Science and the journal Development. The journal covers the mechanisms, diagnostics and treatment of human disease. The journal publishes original research and review articles, and aims to promote communication between basic researchers, translational researchers and...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (4 articles) »
Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related